{"id":57453,"date":"2025-09-19T11:35:37","date_gmt":"2025-09-19T11:35:37","guid":{"rendered":"https:\/\/ibima.eu\/?page_id=57453"},"modified":"2025-11-21T13:05:53","modified_gmt":"2025-11-21T13:05:53","slug":"ep-permed","status":"publish","type":"page","link":"https:\/\/ibima.eu\/en\/ep-permed\/","title":{"rendered":"EP PerMed"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.25.1&#8243; custom_padding=\u00bb||0px|||\u00bb locked=\u00bboff\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_5,3_5,1_5&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb21px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/EPPerMed_Logo_.png\u00bb title_text=\u00bbEPPerMed_Logo_\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb54%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb26px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb59px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbEP PerMed \u2013 Anuncio Convocatoria Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026)\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_text_align=\u00bbleft\u00bb title_text_color=\u00bb#0C71C3&#8243; module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb1px|-78px|||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>La Asociaci\u00f3n Europea para la Medicina Personalizada, <strong data-start=\"275\" data-end=\"288\">EP PerMed <\/strong>lanzar\u00e1 en octubre de 2025 su <strong data-start=\"401\" data-end=\"478\">primera Convocatoria de Investigaci\u00f3n, Innovaci\u00f3n y Tecnolog\u00eda (RITC2026)<\/strong>.<\/p>\n<p>[\/et_pb_text][et_pb_heading title=\u00bbObjetivos de la convocatoria\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.25.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb77.1%\u00bb custom_margin=\u00bb|-259px||161px||\u00bb custom_padding=\u00bb|0px||9px||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb11px|-78px|||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3 data-pm-slice=\"1 3 []\"><span style=\"font-size: 14px; color: #666666;\">La convocatoria financiar\u00e1 proyectos en salud humana centrados en el uso de datos multimodales para enfoques de medicina personalizada, con el objetivo de lograr una gesti\u00f3n m\u00e1s eficiente y personalizada de pacientes con multimorbilidad, es decir, aquellos que presenten al menos dos enfermedades cr\u00f3nicas que requieran tratamiento y que se ajusten a la definici\u00f3n indicada m\u00e1s abajo.<\/span><\/h3>\n<p><strong>Definici\u00f3n de enfermedad cr\u00f3nica:<\/strong> condici\u00f3n de salud de larga duraci\u00f3n (\u2265 6 meses), que requiere tratamiento y afecta de manera significativa a la salud o a las actividades de la vida diaria. Incluye: enfermedades cardiovasculares, metab\u00f3licas, respiratorias, neurol\u00f3gicas, inmunol\u00f3gicas (incluidas autoinmunes), gastrointestinales, urogenitales, c\u00e1ncer y trastornos de salud mental.<\/p>\n<p>Los proyectos deber\u00e1n abordar uno o m\u00e1s de los siguientes aspectos:<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Detecci\u00f3n o caracterizaci\u00f3n de comorbilidades en pacientes con enfermedades cr\u00f3nicas.<\/li>\n<li>Diagn\u00f3stico, seguimiento o monitorizaci\u00f3n de la progresi\u00f3n de la enfermedad, incluidas remisiones y reca\u00eddas.<\/li>\n<li>Fomento del cambio de la atenci\u00f3n hospitalaria a la ambulatoria.<\/li>\n<li>Apoyo a la toma de decisiones en estrategias de intervenci\u00f3n.<\/li>\n<li>Seguimiento y gesti\u00f3n de m\u00faltiples tratamientos para mejorar la eficacia y reducir efectos adversos o interacciones farmacol\u00f3gicas da\u00f1inas.<\/li>\n<li>Mejora de la adherencia a tratamientos a largo plazo.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>Aunque se podr\u00e1n financiar estudios cl\u00ednicos exploratorios (prueba de concepto, fases tempranas o subestudios), <strong>los ensayos cl\u00ednicos de gran envergadura quedan fuera del alcance de esta convocatoria<\/strong>.<\/p>\n<p>Los proyectos financiados deber\u00e1n <strong>probar y desarrollar soluciones innovadoras en entornos reales y controlados<\/strong> (hospitales, atenci\u00f3n ambulatoria, entornos virtuales o cl\u00ednicos simulados).<\/p>\n<p>Las soluciones a probar deber\u00e1n haber alcanzado al menos el <strong>TRL 3<\/strong> (prueba de concepto exitosa en sistemas biol\u00f3gicos relevantes o en datos cl\u00ednicos).<\/p>\n<p>Las innovaciones podr\u00e1n ser <strong>f\u00edsicas<\/strong> (dispositivo, instrumento, kit o herramienta) o <strong>no f\u00edsicas<\/strong> (software, proceso, procedimiento o enfoque novedoso).<\/p>\n<p>Los consorcios deber\u00e1n integrar de forma activa a actores cl\u00ednicos, acad\u00e9micos, empresas (incluidas PYMEs) y entidades sin \u00e1nimo de lucro.<\/p>\n<ul data-spread=\"false\" style=\"text-align: justify;\"><\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bb\u00c1reas prioritarias de inter\u00e9s\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Detecci\u00f3n o caracterizaci\u00f3n de comorbilidades en pacientes cr\u00f3nicos.<\/li>\n<li>Diagn\u00f3stico, seguimiento o monitorizaci\u00f3n de la progresi\u00f3n de la enfermedad.<\/li>\n<li>Impulso de la atenci\u00f3n ambulatoria mediante monitorizaci\u00f3n remota (wearables u otras soluciones tecnol\u00f3gicas).<\/li>\n<li>Apoyo a la toma de decisiones en intervenciones terap\u00e9uticas (tipo de medicaci\u00f3n, dosis, etc.).<\/li>\n<li>Gesti\u00f3n de tratamientos m\u00faltiples para mejorar eficacia y reducir interacciones adversas.<\/li>\n<li>Mejora de la adherencia a tratamientos de larga duraci\u00f3n.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbCondiciones generales\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb|||11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>El consorcio deber\u00e1 contar con <strong>un m\u00ednimo de 3 socios de 3 pa\u00edses distintos y un m\u00e1ximo de 7 socios<\/strong>.<\/li>\n<li>Podr\u00e1n participar socios con financiaci\u00f3n propia, siempre que aporten valor a\u00f1adido al consorcio y presenten una <strong>Letter of Support<\/strong> firmada por una persona con capacidad de representaci\u00f3n.<\/li>\n<li>Es obligatoria la participaci\u00f3n de <strong>al menos un socio cl\u00ednico y un socio industrial<\/strong> (empresa de cualquier tama\u00f1o).<\/li>\n<li>Duraci\u00f3n m\u00e1xima del proyecto: <strong>36 meses<\/strong>.<\/li>\n<li>Pa\u00edses participantes: B\u00e9lgica, Rep\u00fablica Checa, Finlandia, Francia, Irlanda, Israel, Italia, Letonia, Lituania, Portugal, Ruman\u00eda, Rep\u00fablica Eslovaca, Sud\u00e1frica, Espa\u00f1a, Suecia y Turqu\u00eda.<\/li>\n<li>Un investigador principal solo podr\u00e1 <strong>coordinar una propuesta<\/strong>, aunque podr\u00e1 participar como socio en varios proyectos.<\/li>\n<li><strong>Networking<\/strong>: se habilitar\u00e1 una plataforma y se organizar\u00e1 un evento de <em>matchmaking<\/em>. Registro en: <a href=\"https:\/\/www.b2match.com\/e\/online-matchmaking-eppermed-ritc26\">https:\/\/www.b2match.com\/e\/online-matchmaking-eppermed-ritc26<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbFinanciaci\u00f3n de la participaci\u00f3n andaluza\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb|||11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>La financiaci\u00f3n se gestionar\u00e1 a trav\u00e9s de la <strong>Consejer\u00eda de Salud y Consumo de la Junta de Andaluc\u00eda<\/strong>:<\/p>\n<ul>\n<li>Si la entidad andaluza act\u00faa como <strong>coordinadora<\/strong>: hasta <strong>250.000 \u20ac<\/strong> por proyecto.<\/li>\n<li>Si la entidad andaluza act\u00faa como <strong>socia<\/strong>: hasta <strong>125.000 \u20ac<\/strong> por proyecto.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbfechas clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<ul>\n<li>Agosto 2025: Preanuncio de la convocatoria.<\/li>\n<li>1 de octubre 2025: Publicaci\u00f3n oficial de la convocatoria.<\/li>\n<li>28 de octubre 2025: Jornada informativa.<\/li>\n<li>12 de enero 2026: Fecha l\u00edmite para pre-propuestas.<\/li>\n<li>Marzo 2026: Resultados de evaluaci\u00f3n de pre-propuestas e invitaci\u00f3n a fase completa.<\/li>\n<li>27 de abril 2026: Fecha l\u00edmite para propuestas completas.<\/li>\n<li>Finales de junio 2026: Rebuttal.<\/li>\n<li>Septiembre 2026: Comunicaci\u00f3n de resultados.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbDocumentaci\u00f3n y enlaces clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb|||11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/www.eppermed.eu\/funding-projects\/calls\/ritc2026\/\">Web de la convocatoria<\/a><\/li>\n<li><a href=\"https:\/\/www.eppermed.eu\/wp-content\/uploads\/EPPerMed_RITC_MultiPMData2026_call-text_FV.pdf\">Texto de la convocatoria<\/a><\/li>\n<li><a href=\"https:\/\/www.eppermed.eu\/wp-content\/uploads\/2_EPPerMed_RITC2026_GuidelinesApplicants_FV.pdf\">Guidelines<\/a><\/li>\n<li><a href=\"https:\/\/registration.dlr-pt.de\/en\/ep-permed-ritc2026-information-day\/registration\">Registro Infoday<\/a><\/li>\n<li><a href=\"https:\/\/ptoutline.eu\/app\/EPPERMEDRITC2026\">Plataforma de env\u00edo de propuestas<\/a><\/li>\n<li><a href=\"https:\/\/www.eppermed.eu\/wp-content\/uploads\/EPPerMed_RITC_MultiPMData2026_pre-proposal_form.docx\">Template de pre-propuesta<\/a><\/li>\n<li><a href=\"https:\/\/www.b2match.com\/e\/online-matchmaking-eppermed-ritc26\">Plataforma de matchmaking<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#195e7f\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_4,1_4,1_4,1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb50px||50px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2023\/04\/Logoblancofondoazul.jpg\u00bb title_text=\u00bbLogoblancofondoazul\u00bb force_fullwidth=\u00bbon\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb transform_scale_tablet=\u00bb202%|202%\u00bb transform_scale_phone=\u00bb202%|202%\u00bb transform_scale_last_edited=\u00bbon|tablet\u00bb transform_translate_tablet=\u00bb75px|25px\u00bb transform_translate_phone=\u00bb85px|-15px\u00bb transform_translate_last_edited=\u00bbon|phone\u00bb transform_translate_linked_tablet=\u00bboff\u00bb transform_rotate_tablet=\u00bb\u00bb transform_rotate_phone=\u00bb\u00bb transform_rotate_last_edited=\u00bbon|tablet\u00bb transform_skew_tablet=\u00bb\u00bb transform_skew_phone=\u00bb\u00bb transform_skew_last_edited=\u00bbon|tablet\u00bb transform_origin_tablet=\u00bb\u00bb transform_origin_phone=\u00bb\u00bb transform_origin_last_edited=\u00bbon|tablet\u00bb transform_styles_last_edited=\u00bbon|phone\u00bb min_height_tablet=\u00bb\u00bb min_height_phone=\u00bb\u00bb min_height_last_edited=\u00bbon|desktop\u00bb custom_margin_tablet=\u00bb||0px|-5px|false|false\u00bb custom_margin_phone=\u00bb||30px|-17px|false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb custom_padding=\u00bb|200px|||false|false\u00bb custom_padding_tablet=\u00bb0px|200px|||false|false\u00bb custom_padding_phone=\u00bb|200px|||false|false\u00bb custom_padding_last_edited=\u00bbon|desktop\u00bb transform_styles_tablet=\u00bb\u00bb transform_styles_phone=\u00bb\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.0&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb14px|||-11%|false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p class=\"x_MsoNormal\" style=\"text-align: left;\"><span style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px; float: left;\" \/>Avenida Severo Ochoa, 35, 29590, M\u00e1laga<\/span><\/p>\n<p style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/phone.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>952 36 76 00<\/p>\n<p><a href=\"mailto:info@ibima.eu\" data-linkindex=\"0\" id=\"LPlnk315329\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/email.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>info@ibima.eu<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbAPARTADOS PRINCIPALES\u00bb menu_id=\u00bb1332&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.24.0&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb200px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbTEXTOS LEGALES\u00bb menu_id=\u00bb1333&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb-155px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin_tablet=\u00bb5px||||false|false\u00bb custom_margin_phone=\u00bb5px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow_network social_network=\u00bbtwitter\u00bb url=\u00bbhttps:\/\/x.com\/_ibima?lang=es%20&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#000000&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]twitter[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbfacebook\u00bb url=\u00bbhttps:\/\/www.facebook.com\/Ibima.eu\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#3b5998&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]facebook[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbinstagram\u00bb url=\u00bbhttps:\/\/www.instagram.com\/ibima_mlg\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#ea2c59&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]instagram[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bblinkedin\u00bb url=\u00bbhttps:\/\/es.linkedin.com\/company\/ibima\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#007bb6&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]linkedin[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbyoutube\u00bb url=\u00bbhttps:\/\/www.youtube.com\/channel\/UCY3UUZTi9X0ur-1Gd6MKonw\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#a82400&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]youtube[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbBuz\u00f3n de sugerencias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/comunicacion-con-el-instituto\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][dsm_icon_list_child text=\u00bbBuz\u00f3n de denuncias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/canal-de-denuncias\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbSuscr\u00edbete al Canal de Divulgaci\u00f3n\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/forms.gle\/5mczd4KKMqkBPdBy7&#8243; url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Asociaci\u00f3n Europea para la Medicina Personalizada, EP PerMed lanzar\u00e1 en octubre de 2025 su primera Convocatoria de Investigaci\u00f3n, Innovaci\u00f3n y Tecnolog\u00eda (RITC2026).La convocatoria financiar\u00e1 proyectos en salud humana centrados en el uso de datos multimodales para enfoques de medicina personalizada, con el objetivo de lograr una gesti\u00f3n m\u00e1s eficiente y personalizada de pacientes con [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-57453","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EP PerMed - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/ep-permed\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EP PerMed - Ibima\" \/>\n<meta property=\"og:description\" content=\"La Asociaci\u00f3n Europea para la Medicina Personalizada, EP PerMed lanzar\u00e1 en octubre de 2025 su primera Convocatoria de Investigaci\u00f3n, Innovaci\u00f3n y Tecnolog\u00eda (RITC2026).La convocatoria financiar\u00e1 proyectos en salud humana centrados en el uso de datos multimodales para enfoques de medicina personalizada, con el objetivo de lograr una gesti\u00f3n m\u00e1s eficiente y personalizada de pacientes con [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/ep-permed\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-21T13:05:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed\\\/\",\"name\":\"EP PerMed - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\",\"datePublished\":\"2025-09-19T11:35:37+00:00\",\"dateModified\":\"2025-11-21T13:05:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\",\"contentUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EP PerMed\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EP PerMed - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/ep-permed\/","og_locale":"en_GB","og_type":"article","og_title":"EP PerMed - Ibima","og_description":"La Asociaci\u00f3n Europea para la Medicina Personalizada, EP PerMed lanzar\u00e1 en octubre de 2025 su primera Convocatoria de Investigaci\u00f3n, Innovaci\u00f3n y Tecnolog\u00eda (RITC2026).La convocatoria financiar\u00e1 proyectos en salud humana centrados en el uso de datos multimodales para enfoques de medicina personalizada, con el objetivo de lograr una gesti\u00f3n m\u00e1s eficiente y personalizada de pacientes con [&hellip;]","og_url":"https:\/\/ibima.eu\/en\/ep-permed\/","og_site_name":"Ibima","article_modified_time":"2025-11-21T13:05:53+00:00","og_image":[{"url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibima.eu\/es\/ep-permed\/","url":"https:\/\/ibima.eu\/es\/ep-permed\/","name":"EP PerMed - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibima.eu\/es\/ep-permed\/#primaryimage"},"image":{"@id":"https:\/\/ibima.eu\/es\/ep-permed\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","datePublished":"2025-09-19T11:35:37+00:00","dateModified":"2025-11-21T13:05:53+00:00","breadcrumb":{"@id":"https:\/\/ibima.eu\/es\/ep-permed\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/es\/ep-permed\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ibima.eu\/es\/ep-permed\/#primaryimage","url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","contentUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/es\/ep-permed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"EP PerMed"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages\/57453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=57453"}],"version-history":[{"count":6,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages\/57453\/revisions"}],"predecessor-version":[{"id":58464,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages\/57453\/revisions\/58464"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=57453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}